| Name | Title | Contact Details |
|---|
SEIU-UHW is Working for a Healthy California Service Employees International Union-United Healthcare Workers West (SEIU-UHW) is a California union made up of 150,000 healthcare workers who work in hospitals, nursing homes, and in the community as home care providers. Our members are frontline caregivers, including respiratory care practitioners, dietary, environmental services and nursing staff who keep Californians healthy. We live and work throughout California: from the Bay Area to Sacramento and Los Angeles to the Central Valley. Our union of healthcare workers is driven to improve the healthcare system. Our mission is to provide quality care for all patients, expand access to excellent, affordable healthcare for all Californians and improve living standards for all workers.
MS Health has the dope on drugs. The company provides sales management and market research services to clients in the pharmaceutical and health care industries. It tracks not only the sale of prescription drugs and over-the-counter products but also the productivity of individual sales representatives that work for its client companies. It offers market forecasts and surveys to physicians and hospitals about drugs they are prescribing to patients. IMS Health also offers consulting and other professional services.
Victor Treatment Ctr is a Chico, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cellanyx has developed proprietary live tumor cell phenotypic biomarker tests to improve cancer risk-stratification and allow informed clinical decision making. The Companys unique approach provides quantitative and actionable information based on analysis of thousands of live tumor cells. The Companys tests employ a microfluidic platform combined with machine vision and machine learning approaches to analyze phenotypic morphological, biochemical and biophysical markers. Cellanyx has demonstrated initial clinical proof-of-concept with its lead phenotypic test in prostate cancer. The initial clinical proof-of-concept study was conducted to demonstrate improved risk stratification in men with low and intermediate Gleason grade (6 and 7) disease and reduce the number of repeat biopsies. Furthermore, analysis of field samples (away from the suspicious core) demonstrated the potential value of Cellanyx phenotypic test as it was able to analyze the tumor microenvironment conditions and predict expected adverse pathology from samples that were not taken from the suspicious core. These new findings from the Cellanyx prostate test are transformative as it will reduce the errors in diagnosing cancers early due to sampling heterogeneity of prostate biopsies.
Advanced Aeromedical Inc is a Virginia Beach, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.